GET DAILY SIGNALSDXC Technology (DXC) Q2 Fiscal 2027 Results: EPS Beat but Guidance Trimmed
Key Takeaways
- DXC Technology reported second quarter fiscal 2027 revenue of $3.03 billion, down 4.0% year over year but slightly ahead of Wall Street consensus estimates.
- Non-GAAP diluted earnings per share (EPS) came in at $0.67, roughly 22% above analyst expectations, though down from $0.84 a year earlier.
- Management lowered full-year fiscal 2027 guidance to revenue of $11.91 billion to $11.98 billion and non-GAAP diluted EPS of $2.25 to $2.50.
- GAAP EBIT margin narrowed to 2.2% from 5.1% in the prior-year quarter, while free cash flow margin fell to 3%.
- Quarterly bookings totaled $2.4 billion, and the company confirmed ongoing discussions regarding a possible sale of its insurance business.
Why These Results Matter Now
DXC Technology's second quarter fiscal 2027 results arrive at an important juncture for the enterprise IT services provider. The firm has been navigating a multi-year turnaround amid declining discretionary technology spending and ongoing pressure on short-term projects, even as profitability and free cash flow strengthened through fiscal 2026. With about 80% of revenue linked to outcome-based contracts and leadership emphasizing agentic AI solutions, I am watching closely to see if new AI-driven offerings can offset weakness in the core Global Infrastructure Services segment. This update provides a clear signal on demand trends, margin resilience, and the speed of the shift away from legacy services.
Breaking Down the Reported Figures
For the second quarter of fiscal year 2027, ended September 30, 2026, DXC posted total revenue of $3.03 billion, a 4.0% drop from $3.16 billion in the year-ago period. The top line modestly beat consensus estimates, while organic revenue also declined 4% year over year. Non-GAAP diluted EPS of $0.67 exceeded the roughly $0.55 analysts had projected, though it fell from $0.84 in the prior-year quarter. GAAP net income attributable to DXC common stockholders was $24 million, down from $36 million a year earlier, and GAAP EBIT margin narrowed to 2.2% from 5.1%.
Free cash flow reached $91 million, with a free cash flow margin of 3%, down from 7.6% in the same period last year. Bookings totaled $2.4 billion for the quarter. Management guided third quarter fiscal 2027 revenue to around $2.98 billion, below consensus, and lowered full-year fiscal 2027 revenue guidance to $11.91 billion to $11.98 billion, with non-GAAP diluted EPS guidance of $2.25 to $2.50. DXC also noted that discussions continue regarding a possible sale of its insurance business. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Sentiment
Investor reaction to the report turned sharply negative despite the earnings beat, driven largely by the softer forward guidance. Shares fell roughly 15% in the immediate aftermath, as the lowered full-year revenue and EPS outlook overshadowed the quarterly beats. The market focused on the projected revenue decline for the next quarter and the trimmed full-year targets, which pointed to a longer-than-expected recovery in the core business. Weakness in GAAP operating margin and free cash flow margin added to concerns about earnings quality and the staying power of recent profitability improvements.
Forward Outlook and Factors to Watch
Looking ahead, the key question is whether DXC can stabilize its core revenue base while scaling newer AI-led and agentic offerings. The reduced full-year guidance indicates that organic revenue declines will continue in the near term, with the next quarter likely to stay under pressure. I am watching the trajectory of the Global Infrastructure Services segment, which has driven most of the top-line weakness, along with the pace of discretionary project spending among enterprise clients.
Margin trends will matter just as much. The narrowing of GAAP EBIT margin and free cash flow margin in the latest quarter raises questions about how profitability holds up amid revenue declines. Any progress in turning outcome-based contracts and AI-driven productivity gains into sustained margin expansion will draw close attention.
Finally, the possible sale of the insurance business stands out as a potential strategic catalyst. A completed transaction could reshape the portfolio and capital structure, though the timing remains uncertain. Bookings momentum, free cash flow generation, and execution on large contracts will help determine whether the turnaround story regains traction.
Refining My Research Process
When analyzing results like these, I find it helpful to run quick comparisons across peers and screen for similar setups. Tickeron’s AI Screener lets me filter by technical patterns, fundamentals, and AI signals in one place, which speeds up the process of spotting comparable opportunities without manual effort. It has become a regular part of how I cross-check ideas before forming a fuller view.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for DXC turns positive, indicating new upward trend
DXC saw its Momentum Indicator move above the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In 78 of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for DXC just turned positive on October 05, 2026. Looking at past instances where DXC's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
DXC moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DXC crossed bullishly above the 50-day moving average on October 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
The 50-day moving average for DXC moved above the 200-day moving average on October 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where DXC advanced for three days, in 205 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 100 of 144 cases where DXC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
DXC broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. DXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.841) is normal, around the industry mean (2.688). P/E Ratio (21.171) is within average values for comparable stocks, (16.241). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (2.284). Dividend Yield (0.052) settles around the average of (0.133) among similar stocks. P/S Ratio (0.161) is also within normal values, averaging (139.965).
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of technology consulting, outsourcing and support services
Industry InformationTechnologyServices
Advertisement